RELENZA

zanamivir · GlaxoSmithKline LLC

Drug timelines are a Plus or Pro feature.

25 regulatory and trial events tracked for RELENZA, covering 2006-11-22 to 2023-10-24. Get the full timeline:

Most recent: FDA Approved: RELENZA — Supplemental Application (GlaxoSmithKline LLC)